Literature DB >> 20852645

The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site.

Qing Li1, Jianxun Qi, Wei Zhang, Christopher J Vavricka, Yi Shi, Jinhua Wei, Enguang Feng, Jingshan Shen, Jilong Chen, Di Liu, Jianhua He, Jinghua Yan, Hong Liu, Hualiang Jiang, Maikun Teng, Xuebing Li, George F Gao.   

Abstract

Influenza A virus neuraminidase can be classified into groups 1 and 2 on the basis of its primary structure. The main structural feature of group 1 neuraminidase is an extra cavity in the active site, the 150-cavity. Here we present the crystal structure of neuraminidase from the 2009 pandemic H1N1 influenza strain. In contrast to other characterized N1 neuraminidases, which are all members of group 1, 2009 H1N1 neuraminidase does not have a 150-cavity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852645     DOI: 10.1038/nsmb.1909

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  19 in total

1.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

2.  Structural biology: antiviral drugs fit for a purpose.

Authors:  Ming Luo
Journal:  Nature       Date:  2006-08-16       Impact factor: 49.962

3.  Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus.

Authors:  Wei Zhang; Jianxun Qi; Yi Shi; Qing Li; Feng Gao; Yeping Sun; Xishan Lu; Qiong Lu; Christopher J Vavricka; Di Liu; Jinghua Yan; George F Gao
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

4.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution.

Authors:  J N Varghese; W G Laver; P M Colman
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

5.  Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin.

Authors:  Hua Yang; Paul Carney; James Stevens
Journal:  PLoS Curr       Date:  2010-03-22

6.  Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

Authors:  Darwyn Kobasa; Ayato Takada; Kyoko Shinya; Masato Hatta; Peter Halfmann; Steven Theriault; Hiroshi Suzuki; Hidekazu Nishimura; Keiko Mitamura; Norio Sugaya; Taichi Usui; Takeomi Murata; Yasuko Maeda; Shinji Watanabe; M Suresh; Takashi Suzuki; Yasuo Suzuki; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  Nature       Date:  2004-10-07       Impact factor: 49.962

7.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

Review 8.  Influenza virus neuraminidase: structure, antibodies, and inhibitors.

Authors:  P M Colman
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

9.  Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Jeffery K Taubenberger; Peter Palese; David E Swayne; Christopher F Basler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-12       Impact factor: 11.205

10.  Unraveling the mystery of swine influenza virus.

Authors:  Taia T Wang; Peter Palese
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

View more
  74 in total

1.  Binding of herpes simplex virus glycoprotein D to nectin-1 exploits host cell adhesion.

Authors:  Na Zhang; Jinghua Yan; Guangwen Lu; Zhengfei Guo; Zheng Fan; Jiawei Wang; Yi Shi; Jianxun Qi; George F Gao
Journal:  Nat Commun       Date:  2011-12-06       Impact factor: 14.919

2.  Prediction of zanamivir efficiency over the possible 2009 influenza A (H1N1) mutants by multiple molecular dynamics simulations and free energy calculations.

Authors:  Dabo Pan; Huijun Sun; Chongliang Bai; Yulin Shen; Nengzhi Jin; Huanxiang Liu; Xiaojun Yao
Journal:  J Mol Model       Date:  2010-12-31       Impact factor: 1.810

3.  Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins.

Authors:  Song Wang; Hua Li; Yuhai Chen; Haitao Wei; George F Gao; Hongqiang Liu; Shile Huang; Ji-Long Chen
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

4.  Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.

Authors:  Jennifer L McKimm-Breschkin; Janelle Williams; Susan Barrett; Kim Jachno; Mandy McDonald; Peter G Mohr; Takehiko Saito; Masato Tashiro
Journal:  J Antimicrob Chemother       Date:  2013-06-11       Impact factor: 5.790

5.  Structural basis for a class of nanomolar influenza A neuraminidase inhibitors.

Authors:  Philip S Kerry; Sankar Mohan; Rupert J M Russell; Nicole Bance; Masahiro Niikura; B Mario Pinto
Journal:  Sci Rep       Date:  2013-10-16       Impact factor: 4.379

6.  Implications of protein conformations to modifying novel inhibitor Oseltamivir for 2009 H1N1 influenza A virus by simulation and docking studies.

Authors:  Sudha Singh; Anvita Gupta Malhotra; Mohit Jha; Khushhali Menaria Pandey
Journal:  Virusdisease       Date:  2018-09-01

Review 7.  Advances in the development of influenza virus vaccines.

Authors:  Florian Krammer; Peter Palese
Journal:  Nat Rev Drug Discov       Date:  2015-03       Impact factor: 84.694

8.  Multistructural hot spot characterization with FTProd.

Authors:  Lane Votapka; Rommie E Amaro
Journal:  Bioinformatics       Date:  2012-11-29       Impact factor: 6.937

9.  Assembly of subtype 1 influenza neuraminidase is driven by both the transmembrane and head domains.

Authors:  Diogo V da Silva; Johan Nordholm; Ursula Madjo; Annika Pfeiffer; Robert Daniels
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

10.  Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors.

Authors:  Christopher J Vavricka; Yue Liu; Hiromasa Kiyota; Nongluk Sriwilaijaroen; Jianxun Qi; Kosuke Tanaka; Yan Wu; Qing Li; Yan Li; Jinghua Yan; Yasuo Suzuki; George F Gao
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.